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Purpose: Stroke is the second leading cause of death and a major cause of mor-
bidity and mortality worldwide. Evidence of variations in adiponectin (AdipoQ) 
genes that are associated with ischemic stroke has not been consistent, and it is un-
clear whether the same loci contribute to these associations in the Korean popula-
tion. Using a Korean population, we tested ischemic stroke-associated AdipoQ 
markers. Materials and Methods: In a preliminary genome-wide association 
study using 320 250 k Affymetrix NSP chips, AdipoQ was found to be associated 
with ischemic stroke in Koreans. To study of AdipoQ, a further 673 ischemic 
stroke patients and 267 unrelated individuals without a history of stroke or tran-
sient ischemic attack were examined in a case-control study. Results: Six poly-
morphisms (rs182052G > A, rs16861205G > A, rs822391T > C, rs822396A > G, 
rs12495941G > T and rs3774261A > G) that had a minor allele frequency of over 
1% were strongly associated with stroke (p < 0.05). Two of these, rs822391T > C 
and rs822396A > G showed this association on both dominant and additive logis-
tic regression analysis after adjusting for age and sex. The haplotypes ht 1 (AG-
GCGG and AAGTAG) were significantly associated with susceptibility to stroke. 
Conclusion: Our findings show that polymorphisms in AdipoQ are associated 
with risk for ischemic stroke in the Korean population. This study lends further 
support to the putative role of AdipoQ in stroke. 
Key Words: AdipoQ, ischemic, stroke, Koreans
INTRODUCTION
Stroke is the second leading cause of death worldwide and a major cause of mor-
bidity and mortality. According to the Korea National Statistical Office, stroke was 
the second most common cause of death in 2007 (http://www.nso.go.kr).
The clinical phenotype of stroke is broadly divided into ischemic and hemor-
rhagic stroke. Ischemic stroke constitutes 80% to 90% of all cases.1-3 Ischemic 
stroke is divided into 2 principal types: thrombotic and embolic. Thrombotic 
stroke can also be subdivided into large-vessel occlusion and small-vessel occlu-Association of AdipoQ gene Variations with Stroke
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gene in the Korean population.
MATERIALS AND METHODS
Subjects 
A preliminary experiment examined 160 normal healthy 
subjects and 160 stroke patients who were recruited from 
the Korean Institute of Oriental Medicine (KIOM). The fol-
low-up experiment examined 673 ischemic stroke cases 
and 267 healthy controls recruited from KIOM. Informed 
consent was obtained from all participants through KIOM, 
and our research was approved by the research ethical com-
mittee of KIOM.
Candidate gene and marker selection
In the preliminary experiment with 320 Affymetrix 250 k 
NSP chips, SNPs in genes that were associated with the 
combined phenotype of ischemic stroke were identified (p 
< 0.01), and we selected several SNPs within the 100-kb 
upstream and downstream regions (using the Affymetrix 
annotation file; Mapping205K_Nsp.na22.annot.csv). We 
searched the GeneCards, OMIM, and PubMed databases 
and found 768 stroke-related genes compared with the 
SNPs in the preliminary experiment.
In a follow-up association analysis (the Illumina Golden 
Gate experiment), we selected 10 tag SNPs in the AdipoQ 
gene, which was one of the candidate genes related to isch-
emic stroke. The 10 tag SNPs were selected if they had an 
efficiency of more than 80% using Haploview and Hap-
Map Japanese data (http://www.hapmap.org).
Statistical analysis
Differences in clinical characteristics between the 2 groups 
were determined by a Student’s t-test for continuous vari-
ables [age, body-mass index (BMI)] and a Chi-squared test 
for categorical variables (sex, hypertension, diabetes melli-
tus, and hypercholesterolemia). The Chi-squared test was 
used to measure Hardy-Weinberg equilibrium (HWE) for 
comparing allele and genotype frequencies between cases 
and controls. The relative risk for stroke associated with 
genotype in the case-control analysis was calculated with 
odds ratios (ORs) [95% confidence interval (CI)] using lo-
gistic regression models and corresponding p values, while 
controlling for age and sex as covariates [software: PLINK 
(v1.03, http://pngu.mgh.harvard.edu/~purcell/plink/)].
Three alternative models for the minor alleles-codomi-
sion, correlating with the location of the blockage within 
the brain. Therefore, stroke does not appear to be defined as 
a single disease or one distribution.4 The proportion of 
small-vessel occlusion is relatively high in Korea as com-
pared to Western countries.5 The identification of a reliable 
genetic risk factor for stroke is important. 
Adiponectin is also called GBP-28, apM1, AdipoQ, and 
Acrp30.6 It was identified as an adipocytokine, a 244-ami-
no-acid protein, the product of the AdipoQ gene, which is 
highly expressed in adipose cells.7 AdipoQ, a novel adipose 
tissue-specific protein, is a structural homolog of collagen 
VIII and X, complement factor C1q, and tumor necrosis 
factor-α (TNFα).7-10 AdipoQ regulates the homeostasis of 
glucose, energy storage, and fatty acid metabolism11,12 and 
acts as an anti-inflammatory13 and antiatherogenic plasma 
protein.14,15
AdipoQ is associated with obesity, metabolic syndrome, 
type 2 diabetes mellitus, hypertension, and coronary artery 
diseases. Furthermore, low levels of plasma adiponectin 
have been linked to ischemic cerebrovascular disease 
(CVD).15-23 In comparing type 2 diabetes patients to con-
trols, it can be seen that AdipoQ mRNA levels are reduced 
in adipose tissue, although they are normal levels in circu-
lating adiponectin.
The adiponectin (AdipoQ) gene is located on chromo-
some 3q27.24-26 AdipoQ gene variations are associated with 
changes in plasma adiponectin concentration. Variations in 
the AdipoQ gene also correlate with ischemic stroke in 
some populations. In American,27 Japanese,28 Greece29 and 
European30 populations, AdipoQ is associated with isch-
emic stroke. The aim of the present study was to investigate 
this association in a Korean population.
We used 320 250 k Affymetrix NSP chips (Affymetrix 
Inc., Santa Clara, CA, USA) in a stroke case and control as-
sociation study. In this genome-wide association chip ex-
periment, many single nucleotide polymorphisms (SNPs) 
in several genes, including AdipoQ, were associated with 
ischemic stroke. We queried the GeneCards, Online Men-
delian Inheritance in Man (OMIM), and PubMed databases 
to identify stroke-related genes and compared them with 
the SNPs from the preliminary experiments.
To test whether AdipoQ was a candidate gene that was 
linked to the Korean population, we obtained 10 tag SNPs 
of the AdipoQ gene. Then, we performed an Illumina Gold-
en Gate experiment using samples from 940 Koreans to de-
termine any association with the markers. In this study, we 
identify the markers that are associated with the AdipoQ My-Young Cheong, et al.
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182052, rs16861205, rs822391, rs822396, rs12495941, and 
rs3774261 (Table 3)-as determined by the chi-squared test 
(p < 0.05). The 6 polymorphisms were further examined in 
a more rigorous evaluation of association by multivariable 
logistic regression analysis, adjusting for sex and age. Geno-
types were assessed as either dominant, recessive, or addi-
tive. Two SNPs (rs822391T > C and rs822396A > G) were 
more highly associated with risk of stroke in the dominant 
and additive analyses. 
The genomic positions of the 10 SNPs in the AdipoQ 
gene are shown in Fig. 1A. We performed haplotype-based 
conditional logistic regression analysis, adjusting for sex 
and age (Table 4). The haplotypes AGGCGG and AAG-
TAG in ht1 showed the most preventive effect in stroke (p 
= 0.029 and 0.050, respectively).
DISCUSSION
There are few studies of the association between the Adi-
poQ gene and stroke. Several studies have linked AdipoQ 
gene variations to the risk of stroke. Five AdipoQ genetic 
variations (rs266729, rs182052, rs822396, rs2241766, and 
rs1501299) were examined for their association with inci-
dent myocardial infarction or ischemic stroke in a Cauca-
sian population;27 in this study, rs266729 and rs182052, and 
the haplotype G-A-G (comprising rs266729, rs182052, and 
rs822396) were correlated with a risk of ischemic stroke, ir-
respective of diabetes. The rs266729C > G polymorphism 
of the AdipoQ gene has been associated with atherothrom-
botic cerebral infarction in Japanese individuals with a met-
abolic syndrome.28
AdipoQ gene variations are associated with plasma adipo-
nectin concentrations, and metabolic syndrome is a risk fac-
tor for cardiovascular disease and also associated with plas-
ma adiponectin concentrations. Therefore, AdipoQ gene 
nant, dominant, and recessive-were applied in our analyses. 
For each OR, we calculated 95% CIs. Association analysis 
of the haplotypes was performed using Haploview (v 4.1). 
Logistic regression models were used to estimate odds ra-
tios that assessed the association between AdipoQ haplo-
types and stroke, adjusting for sex and age [software: 
PLINK (v1.03)]. A 2-tailed p value < 0.05 was significant.
RESULTS
The distribution of stroke types in our study is shown in Ta-
ble 1. The proportion of small-vessel occlusion cases was 
relatively high, and that of cardiac embolism was low, as in 
a previous study.5 The principal characteristics of the sub-
jects in the AdipoQ gene association study are shown in Ta-
ble 2. Stroke patients experienced a higher prevalence of 
hypertension, diabetes mellitus, and hypercholesterolemia 
than the normal controls. This profile was similar to that of a 
previous study in Koreans, in which hypertension was pres-
ent in 60% to 70%, diabetes mellitus in 25% to 30%, and hy-
percholesterolemia in 15% to 20% of stroke patients.5 BMI 
was not significantly different between the two groups. How-
ever, these risk factors were not adjusted for because of the 
large number of similar missing values within each group.
From the selected candidate genes, we identified 10 inde-
pendent tag SNPs in the AdipoQ gene using public databas-
es. The 10 SNPs had a minor allele frequency (MAF) of ≥ 
0.05 and a Hardy-Weinberg equilibrium p value of  ≥ 
0.00001. Six SNPs were significantly related to strokers 
Table 1. Ischemic Stroke Subtypes
Subtypes n (%)
Large-vessel 160 (23.77)
Small-vessel 483 (71.77)
Cardioembolic 30 (4.46)
Table 2. Clinical Profiles of the Subjects
Clinical profile Normal controls Stroke patients
Number of subjects 267 673
Age (mean ± SD)* 59.9 ± 9.8   67.1 ± 12.8
Sex (male / female)* 110 / 157 366 / 307
BMI, kg/m
2 (mean ± SD) 24.3 ± 3.2 23.6 ± 4.1
Hypertension, %* 2.2 63.9
Diabetes mellitus, %* 1.1 27.9
Hypercholesterolemia, %* 7.1 19.9
BMI, body-mass index.
*p value < 0.05 for the difference between stroke patients and normal controls.Association of AdipoQ gene Variations with Stroke
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variations may be linked to susceptibility to ischemic stroke.
In our study, we found evidence for the association of 
AdipoQ gene variations/haplotypes with ischemic stroke in 
the Korean population. We found that rs822391T > C and 
rs822396A > G were related to an increased risk for isch-
emic stroke in the dominant and additive analyses. Even 
though we do not know the exact inheritance mode of Adi-
poQ gene, according to the association results, we may drop 
the AdipoQ recessive inheritance in stroke causation or sus-
ceptibility. Furthermore, a haplotype block (comprising 
rs182052, rs16861205, rs822391, rs822396, rs12495941, 
and rs3774261) that contained the haplotypes AGGCGG 
and AAGTAG was associated with ischemic stroke. 
We identified associated genes in a genome-wide com-
mercial SNP chip experiment and compared them with 
candidate genes from public databases in non-Korean pop-
ulations, such as GeneCards, OMIN, and PubMed. Further-
more, we verified these results by analyzing 10 SNPs in the 
AdipoQ gene in 940 subjects. Similar, significant genetic risk 
factors for ischemic stroke were also observed in American,27 
Japanese,28 Greek,29 and general European30  populations. 
Stroke is the second leading cause of death in Koreans 
and a major cause of morbidity and mortality around the 
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Map of AdipoQ gene on chromosome 3q27. (B) LD Blocks.
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mone adiponectin in human disease. Eur J Endocrinol 2003;148: 
293-300.
7. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, 
Matsubara K. cDNA cloning and expression of a novel adipose 
specific collagen-like factor, apM1 (AdiPose Most abundant Gene 
transcript 1). Biochem Biophys Res Commun 1996;221:286-9. 
8. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A 
novel serum protein similar to C1q, produced exclusively in adi-
pocytes. J Biol Chem 1995;270:26746-9.
9. Nakano Y, Tobe T, Choi-Miura NH, Mazda T, Tomita M. Isolation 
and characterization of GBP28, a novel gelatin-binding protein 
purified from human plasma. J Biochem 1996;120:803-12.
10. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-spe-
cific gene dysregulated in obesity. J Biol Chem 1996;271:10697-
703.
11. Goldstein BJ, Scalia R. Adiponectin: A novel adipokine linking 
adipocytes and vascular function. J Clin Endocrinol Metab 2004; 
89:2563-8.
12. Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K. Obesity, 
adiponectin and vascular inflammatory disease. Curr Opin Lipidol 
2003;14:561-6.
13. Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ou-
chi N, et al. Adiponectin, a new member of the family of soluble 
defense collagens, negatively regulates the growth of myelomono-
cytic progenitors and the functions of macrophages. Blood 
2000;96:1723-32.
14. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, 
et al. Novel modulator for endothelial adhesion molecules: adipo-
cyte-derived plasma protein adiponectin. Circulation 1999;100: 
2473-6.
15. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, 
et al. Adiponectin, an adipocyte-derived plasma protein, inhibits 
endothelial NF-kappaB signaling through a cAMP-dependent 
pathway. Circulation 2000;102:1296-301.
16. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et 
al. Paradoxical decrease of an adipose-specific protein, adiponectin, 
world, and the role of inflammation may be important.27 
AdipoQ acts as an anti-inflammatory13 and antiatherogenic 
plasma protein.14,15 AdipoQ gene variations are associated 
with obesity, metabolic syndrome, type 2 diabetes mellitus, 
hypertension, coronary artery disease, and ischemic CVD. 
The five population studies-in Americans,27 Japanese,28 
Greece,29 European30 and Koreans (our study)-suggest that 
polymorphisms in AdipoQ increase susceptibility to stroke. 
Therefore, further functional molecular biology and genetic 
studies are needed to explain the mechanics of this link. 
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